We present a case of bile duct adenoma that mimicked hepatic metastasis from gastric cancer. The adenoma exhibited prolonged enhancement on dynamic computed tomography, hyperintensity on diŠusion-weighted imaging, and diminished uptake of superparamagnetic iron oxide and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid on magnetic resonance imaging, resembling those of adenocarcinomas. Knowledge of the imagingˆndings of this rare entity may aid correct diagnosis.
Introduction
Intrahepatic bile duct adenoma (BDA) is a rare benign epithelial tumor of the liver that is generally discovered incidentally during laparotomy or autopsy because of the lack of symptoms and small tumor size (one to 20 mm; mean, 5.8 mm). 1 Histopathologically, BDA consists of a small aggregate of noncystic bile ductules associated with variable degrees of in‰ammation andˆbrosis. 1 Its etiology remains unclear. Previous reports have suggested that BDA is a reactive process to focal injury 1 or a hamartoma that represents disorganized peribiliary glands. 2 Computed tomography (CT) and magnetic resonance (MR) imaging are useful for detecting and diagnosing liver tumors. Detection of BDA will increase with the expanded use of and advances in cross-sectional imaging modalities, such as ultrasonography, CT, and MR imaging. However, only a few reports in the English literature describe imagingˆndings of BDA. [3] [4] [5] To our knowledge, no imagingˆndings of BDA have been reported for diŠusion-weighted (DWI) and superparamagnetic iron oxide (SPIO)-enhanced MR imaging.
We present a case of BDA in a patient with gastric cancer and describeˆndings on unenhanced and contrast-enhanced multidetector CT (MDCT) and MR imaging that included DWI and enhancement using SPIO and gadolinium-ethoxybenzyldiethylenetriamine pentaacetic acid (Gd-EOB-DT-PA). The benign tumor mimicked hepatic metastasis from gastric cancer.
Case Report
A 65-year-old woman with upper abdominal pain was referred to our hospital. Results of laboratory tests, including complete blood count, liver function tests, and tumor markers, were within normal limits. Esophagogastroduodenoscopy revealed an ulcerated lesion in the posterior wall of the body of the stomach. The gastric lesion was biopsied and determined pathologically to be adenocarcinoma. Preoperative ultrasonography revealed a hypoechoic nodule of 8-mm diameter near the hepatic capsule in the medial segment of the liver. MDCT was performed with a 16-MDCT scanner (Aquilion; Toshiba Medical Systems, Japan). The lesion was hypodense on unenhanced CT (Fig. 1A ) and showed ring enhancement during the arterial phase (Fig. 1B) and isoattenuation compared to the surrounding liver parenchyma during the portal-venous phase (Fig. 1C) 2B) . However, the BDA displayed clear hyperintensity on DWI ( Fig. 2C ) with an apparent diŠusion coe‹cient (ADC) value of 1.10×10 -3 mm 2 /s. There was no signal drop in the lesion on SPIO-enhanced T 2 * -weighted imaging (TR, 205 ms; TE, 9.84 ms; FA, 609 ) (Fig. 2D) . On Gd-EOB-DTPAenhanced MR imaging using 3-dimensional fat-suppressed T 1 -weighted gradient-echo volumetric interpolated breath-hold examination (TR, 3.4 ms; TE, 1.24 ms; FA, 109 ), the lesion showed peripheral enhancement during the hepatic arterial phase and relative hypointensity compared to the surrounding liver parenchyma during the portal and transitional phases but distinct hypointensity during the hepatobiliary phase (Fig. 2E) . Theseˆnd-ings suggested hepatic metastasis from gastric cancer. The patient received systemic chemotherapy using combined anticancer drugs tegafur, gimeracil, and oteracil potassium. After 5 months, the gastric lesion decreased in size, but the hepatic lesion did not change. The patient underwent total gastrectomy and wedge resection of the hepatic lesion. Grossly, the resected specimen of the liver had a well deˆned and nonencapsulated yellowish white solid lesion (Fig. 3A) . Microscopic examination revealed proliferation of epithelial cells of the bile ductules in the peripheral area (Fig. 3B) , which cor- responded to the area that showed ring enhancement during the arterial phase on dynamic CT. The central area that showed delayed enhancement on dynamic CT corresponded to denseˆbrous stroma (Fig. 3C) . Immunohistochemical examination demonstrated positive staining for cytokeratin 7 and 19. Pathological diagnosis of the liver lesion was BDA and of the gastric lesion, poorly diŠerentiated adenocarcinoma.
Discussion
Only 3 reports in the English literature have included radiologicalˆndings of 5 BDAs. [3] [4] [5] Table  summarizes the imagingˆndings of those cases and ours. Five of the 6 BDAs (including our case) showed delayed or prolonged enhancement during the late phase in dynamic CT. This enhancement pattern may be attributable to abundantˆbrous stroma within the tumor and resembles the pattern of adenocarcinomas with abundantˆbrous stroma, such as cholangiocarcinoma and metastasis from cancer of the gastrointestinal tract cancer. 6 In our case, we observed delayed enhancement in the central area with denseˆbrous stroma.
On T 2 -weighted MR imaging, most metastatic adenocarcinomas are hyperintense, but some adenocarcinomas with denseˆbrosis exhibit iso-or hypointensity. On T 2 -weighted imaging, four of the 5 previously reported BDAs exhibited hyperinten- 
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sity; theˆfth exhibited hypointensity. Our case exhibited isointensity on T 2 -weighted imaging, which could be attributed to abundantˆbrous stroma within the lesion. Our case of BDA exhibited hyperintensity on DWI. DWI re‰ects changes in tissue water mobility, provides diŠerent tissue contrast from that of conventional T 1 -and T 2 -weighted imaging, and has been used to detect and diagnose liver tumors. 7, 8 Parikh and colleagues 8 reported the superiority of DWI to standard T 2 -weighted imaging for detecting focal hepatic lesions. We clearly visualized the BDA in our case on DWI, but it was not clear on T 2 -weighted imaging. The ADC value was 1.10×10 -3 mm 2 /s in the present case. The ADC values of focal nodular hyperplasias and liver cell adenomas have been reported to be similar to those of hepatocellular carcinomas (HCCs) and metastases. 7 Thus, it might be di‹cult to diŠerentiate BDA from hepatic metastasis on the basis of DWI.
SPIO is a tissue-speciˆc MR imaging agent taken up by KupŠer cells in the liver. Gd-EOB-DTPA is a new hepatocyte-speciˆc contrast agent taken up by hepatocytes during the hepatobiliary phase. SPIOand Gd-EOB-DTPA-enhanced MR images are used to improve detection and characterization of focal hepatic lesions in clinical studies. 9, 10 On SPIO-enhanced MR imaging, we visualized the present BDA as an area of diminished SPIO uptake, such as that observed in hepatic metastatic lesions. During the hepatobiliary phase of Gd-EOB-DTPA-enhanced MR imaging, our case and one previously reported case 5 demonstrated distinct hypointensity. As with a hepatic metastatic lesion, a BDA lacks KupŠer cells and normal hepatocytes, which results in diminution of SPIO and Gd-EOB-DTPA uptake and di‹culty in diŠerentiating BDA from malignant liver tumors. This is theˆrst report on DWI and SPIO-enhanced MR imagingˆndings of BDA. DWI is useful for detection and characterization of hepatic tumors. 7 SPIO-and Gd-EOB-DTPA-enhanced MR imaging can improve sensitivity in detecting hepatic metastatic lesions. 9,10 However, we found it di‹cult to diŠerentiate BDA from a hepatic metastatic lesion from gastric cancer, even with the combination of dynamic CT, DWI, and SPIO-and Gd-EOB-DTPA-enhanced MR imaging. Though rare, BDA should be included in the diŠerential diagnosis of small hypervascular and prolonged-enhancing tumors in the periphery of the liver. 
